Lulu Cheng

机构：Anhui Agricultural University, Sun Yat-sen University, Guangdong Pharmaceutical University · ORCID：0000-0001-6895-1775

发表论文 66 篇 · 总被引 856 次 · h-index 15

代表论文

• First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours (2024 · BMJ Oncology · 被引 51)
• Understanding the CaCO3 phase transition of carbonated wollastonite composites caused by sodium tripolyphosphate: From amorphous to crystalline (2024 · Cement and Concrete Composites · 被引 33)
• Aggregation-induced emission-active iridium (III)-based mitochondria-targeting nanoparticle for two-photon imaging-guided photodynamic therapy (2023 · Journal of Colloid and Interface Science · 被引 20)
• LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway (2024 · Journal of Cancer Research and Clinical Oncology · 被引 19)
• Corrosion-induced deterioration and fracture mechanisms in ultra-high-performance fiber-reinforced concretet (2024 · Construction and Building Materials · 被引 16)
• Investigation of the dynamic mechanical response of corroded ultra-high performance fiber reinforced concrete (UHPFRC) with initial defects (2024 · Cement and Concrete Composites · 被引 15)